416 related articles for article (PubMed ID: 17949561)
1. Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature.
Almoznino G; Ben-Chetrit E
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S99-102. PubMed ID: 17949561
[TBL] [Abstract][Full Text] [Related]
2. Treatment of recalcitrant orogenital ulceration of Behçet's syndrome with infliximab.
Robertson LP; Hickling P
Rheumatology (Oxford); 2001 Apr; 40(4):473-4. PubMed ID: 11312390
[No Abstract] [Full Text] [Related]
3. Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept.
Olivieri I; D' Angelo S; Padula A; Leccese P; Mennillo GA
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S112. PubMed ID: 19796550
[No Abstract] [Full Text] [Related]
4. [Behçet's disease - Infliximab in the treatment of mucocutaneous manifestations].
Lestre S; Trindade F; Martins A; Baptista J; Feio AB; Lopes MJ
Acta Reumatol Port; 2009; 34(4):633-40. PubMed ID: 20852576
[TBL] [Abstract][Full Text] [Related]
5. Infliximab treatment for severe orogenital ulceration in Behçet's disease.
Connolly M; Armstrong JS; Buckley DA
Br J Dermatol; 2005 Nov; 153(5):1073-5. PubMed ID: 16225632
[No Abstract] [Full Text] [Related]
6. Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody.
Travis SP; Czajkowski M; McGovern DP; Watson RG; Bell AL
Gut; 2001 Nov; 49(5):725-8. PubMed ID: 11600479
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab.
Ju JH; Kwok SK; Seo SH; Yoon CH; Kim HY; Park SH
Clin Rheumatol; 2007 Aug; 26(8):1383-5. PubMed ID: 17039261
[TBL] [Abstract][Full Text] [Related]
8. Late response to anti-TNF-α therapy in refractory mucocutaneous lesions of Behçet's disease.
Aikawa NE; Gonçalves C; Silva CA; Gonçalves C; Bonfá E; de Carvalho JF
Rheumatol Int; 2011 Aug; 31(8):1097-9. PubMed ID: 20012049
[TBL] [Abstract][Full Text] [Related]
9. [Behçet's disease].
Brand HS; van Beusichem FF; van Nieuw Amerongen A
Ned Tijdschr Tandheelkd; 2008 Jun; 115(6):340-5. PubMed ID: 18618988
[TBL] [Abstract][Full Text] [Related]
10. Long-term remission of ocular and extraocular manifestations in Behçet's disease using infliximab.
Handa T; Tsunekawa H; Yoneda M; Watanabe D; Mukai T; Yamamura M; Iwaki M; Zako M
Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S58-63. PubMed ID: 21968238
[TBL] [Abstract][Full Text] [Related]
11. Infliximab for refractory oral ulcers.
Ryu HJ; Seo MR; Choi HJ; Baek HJ
Am J Otolaryngol; 2014; 35(5):664-8. PubMed ID: 24962948
[TBL] [Abstract][Full Text] [Related]
12. Conjunctival ulcers in Behçet's disease.
Zamir E; Bodaghi B; Tugal-Tutkun I; See RF; Charlotte F; Wang RC; Wechsler B; LeHoang P; Anteby I; Rao NA
Ophthalmology; 2003 Jun; 110(6):1137-41. PubMed ID: 12799237
[TBL] [Abstract][Full Text] [Related]
13. Resolution of Behçet's syndrome associated pulmonary arterial aneurysms with infliximab.
Schreiber BE; Noor N; Juli CF; Haskard DO
Semin Arthritis Rheum; 2011 Dec; 41(3):482-7. PubMed ID: 21546064
[TBL] [Abstract][Full Text] [Related]
14. Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet's disease: report of a case.
Byeon JS; Choi EK; Heo NY; Hong SC; Myung SJ; Yang SK; Kim JH; Song JK; Yoo B; Yu CS
Dis Colon Rectum; 2007 May; 50(5):672-6. PubMed ID: 17216141
[TBL] [Abstract][Full Text] [Related]
15. Trial of Apremilast for Oral Ulcers in Behçet's Syndrome.
Hatemi G; Mahr A; Ishigatsubo Y; Song YW; Takeno M; Kim D; Melikoğlu M; Cheng S; McCue S; Paris M; Chen M; Yazici Y
N Engl J Med; 2019 Nov; 381(20):1918-1928. PubMed ID: 31722152
[TBL] [Abstract][Full Text] [Related]
16. Infliximab in refractory uveitis due to Behçet's disease.
Wechsler B; Sablé-Fourtassou R; Bodaghi B; Huong DL; Cassoux N; Badelon I; Fain O; LeHoang P; Piette JC
Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S14-6. PubMed ID: 15515776
[TBL] [Abstract][Full Text] [Related]
17. Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report.
Gulli S; Arrigo C; Bocchino L; Morgante L; Sangari D; Castagna I; Bagnato GF
BMC Musculoskelet Disord; 2003 Aug; 4():19. PubMed ID: 12946278
[TBL] [Abstract][Full Text] [Related]
18. Apremilast for Behçet's syndrome--a phase 2, placebo-controlled study.
Hatemi G; Melikoglu M; Tunc R; Korkmaz C; Turgut Ozturk B; Mat C; Merkel PA; Calamia KT; Liu Z; Pineda L; Stevens RM; Yazici H; Yazici Y
N Engl J Med; 2015 Apr; 372(16):1510-8. PubMed ID: 25875256
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature.
Hatemi I; Hatemi G; Pamuk ON; Erzin Y; Celik AF
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S129-37. PubMed ID: 26486925
[TBL] [Abstract][Full Text] [Related]
20. An incomplete form of childhood Behçet's disease treated with infliximab.
Caporuscio S; Pranteda G; Nistico S; Maucione T; Canzoni M; Stefani A; Muscianese M; Fanto M; Sorgi M
Int J Immunopathol Pharmacol; 2014; 27(3):445-8. PubMed ID: 25280037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]